Quick Answer
NEUROCRINE BIOSCIENCES INC reported Total Assets of $4.63 billion for fiscal year 2025.
NEUROCRINE BIOSCIENCES INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.63B | +24.5% |
| 2024 | $3.72B | +14.4% |
| 2023 | $3.25B | +37.3% |
| 2022 | $2.37B | +14.3% |
| 2021 | $2.07B | +19.5% |
| 2020 | $1.73B | +32.8% |
| 2019 | $1.31B | +31.5% |
| 2018 | $993.15M | +21.5% |
| 2017 | $817.59M | +123.9% |
| 2016 | $365.09M | -23.1% |
| 2015 | $474.79M | +95.4% |
| 2014 | $243.03M | +57.1% |
| 2013 | $154.68M | -21.1% |
| 2012 | $195.98M | +41.6% |
| 2011 | $138.37M | -4.2% |
| 2010 | $144.42M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.27B | +20.7% | +9.7% |
| June 30, 2025 | $3.89B | +17.7% | +5.5% |
| March 31, 2025 | $3.69B | +6.2% | -0.8% |
| December 31, 2024 | $3.72B | +14.4% | +5.2% |
| September 30, 2024 | $3.54B | +24.1% | +7.0% |
| June 30, 2024 | $3.31B | +26.5% | -4.8% |
| March 31, 2024 | $3.47B | +47.1% | +6.8% |
| December 31, 2023 | $3.25B | +37.3% | +14.2% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +24.5% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, NEUROCRINE BIOSCIENCES INC’s total assets has grown by 3106.9% (from $144.42 million to $4.63 billion).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: